These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29624903)
1. Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression. Pedersen HL; Horvei KD; Thiyagarajan D; Norby GE; Seredkina N; Moroni G; Eilertsen GØ; Holdaas H; Strøm EH; Bakland G; Meroni PL; Rekvig OP J Pathol Clin Res; 2018 Jul; 4(3):193-203. PubMed ID: 29624903 [TBL] [Abstract][Full Text] [Related]
2. Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis. Fismen S; Thiyagarajan D; Seredkina N; Nielsen H; Jacobsen S; Elung-Jensen T; Kamper AL; Johansen SD; Mortensen ES; Rekvig OP Am J Pathol; 2013 Mar; 182(3):688-700. PubMed ID: 23273922 [TBL] [Abstract][Full Text] [Related]
3. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. Zykova SN; Tveita AA; Rekvig OP PLoS One; 2010 Aug; 5(8):. PubMed ID: 20856893 [TBL] [Abstract][Full Text] [Related]
4. Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis. Seredkina N; Rekvig OP Am J Pathol; 2011 Sep; 179(3):1120-8. PubMed ID: 21723244 [TBL] [Abstract][Full Text] [Related]
5. Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease. Horvei KD; Pedersen HL; Fismen S; Thiyagarajan D; Schneider A; Rekvig OP; Winkler TH; Seredkina N PLoS One; 2017; 12(11):e0188863. PubMed ID: 29190833 [TBL] [Abstract][Full Text] [Related]
6. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. Fenton K; Fismen S; Hedberg A; Seredkina N; Fenton C; Mortensen ES; Rekvig OP PLoS One; 2009 Dec; 4(12):e8474. PubMed ID: 20041189 [TBL] [Abstract][Full Text] [Related]
7. Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of Toll like receptors and the Clec4e. Thiyagarajan D; Fismen S; Seredkina N; Jacobsen S; Elung-Jensen T; Kamper AL; Fenton CG; Rekvig OP; Mortensen ES PLoS One; 2012; 7(3):e34080. PubMed ID: 22479529 [TBL] [Abstract][Full Text] [Related]
8. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [TBL] [Abstract][Full Text] [Related]
11. Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis. Soliman S; Mohamed FA; Ismail FM; Stanley S; Saxena R; Mohan C Int J Rheum Dis; 2017 Nov; 20(11):1714-1727. PubMed ID: 29076253 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis. Ding H; Kharboutli M; Saxena R; Wu T Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478 [TBL] [Abstract][Full Text] [Related]
13. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922 [TBL] [Abstract][Full Text] [Related]
14. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582 [TBL] [Abstract][Full Text] [Related]
15. Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells. Castellano G; Cafiero C; Divella C; Sallustio F; Gigante M; Pontrelli P; De Palma G; Rossini M; Grandaliano G; Gesualdo L Arthritis Res Ther; 2015 Mar; 17(1):72. PubMed ID: 25889472 [TBL] [Abstract][Full Text] [Related]
16. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy. Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545 [TBL] [Abstract][Full Text] [Related]